2017
DOI: 10.1016/j.cbpra.2016.05.008
|View full text |Cite
|
Sign up to set email alerts
|

A New CBT Model of Panic Attack Treatment in Comorbid Heart Diseases (PATCHD): How to Calm an Anxious Heart and Mind

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
20
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 25 publications
(21 citation statements)
references
References 61 publications
1
20
0
Order By: Relevance
“…Evidence-based PT is also not available as standard CBT for anxiety disorders (including exposure therapy) can have adverse somatic effects in CAD patients ( 34 37 ), and no adaptation for this patient population has yet been implemented. However, the PATCHD trial recently proved feasibility of such an adaption ( 15 ).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Evidence-based PT is also not available as standard CBT for anxiety disorders (including exposure therapy) can have adverse somatic effects in CAD patients ( 34 37 ), and no adaptation for this patient population has yet been implemented. However, the PATCHD trial recently proved feasibility of such an adaption ( 15 ).…”
Section: Discussionmentioning
confidence: 99%
“…Although anxiety disorders are as common in CAD patients as depressive disorders (unpublished data), research on their treatment is even scarcer ( 14 ). Panic disorder was successfully treated in CAD patients in the small PATCHD trial ( 15 ) and additional CBT reduced somatic anxiety in the SUPRIM trial ( 12 , 13 ). In addition, little is known about the utilization rates of mental health-care services by patients with CAD and comorbid affective or anxiety disorders, as well as about effectiveness of general mental health care in CAD patients outside of the research setting.…”
Section: Introductionmentioning
confidence: 99%
“…Several effective evidence-based supports are available to assist patients to manage anxiety and depression, underscoring the importance of early identification of at-risk patients. Cognitive behaviour therapy (CBT) has been shown to be effective in reducing anxiety and depression in cardiac patients (Ski et al, 2016;Tully et al, 2017), as has cost-effective short term psychotherapy (Pristipino et al, 2019) and low intensity collaborative care (Huffman et al, 2014). Selective serotonin reuptake inhibitors (SSRIs) are effective for cardiac patients with depression, both for remission of depressive symptoms (Thombs et al, 2008;Pizzi et al, 2011;Kim et al, 2018) and reduced incidents of re-events and death (Taylor et al, 2005;Kim et al, 2018).…”
Section: Introductionmentioning
confidence: 99%
“…Indeed, cognitive-behavioral treatment (CBT) for addressing anxiety and fear in patients with cardiopulmonary disease can be challenging given the significant overlap in cardiac and pulmonary symptoms and symptoms of anxiety. [10][11] Therefore, increased scholarly attention to nuanced aspects of patients' fears and practitioners' understanding of such fears has the potential to bolster treatment development efforts. We examined fear about exercise and avoidance behaviors in patients enrolled in outpatient CVPR, and practitioners' beliefs and behaviors related to anxiety and fear about exercise.…”
mentioning
confidence: 99%